Translational Psychiatry (Feb 2021)

Long runs of homozygosity are associated with Alzheimer’s disease

  • Sonia Moreno-Grau,
  • Maria Victoria Fernández,
  • Itziar de Rojas,
  • Pablo Garcia-González,
  • Isabel Hernández,
  • Fabiana Farias,
  • John P. Budde,
  • Inés Quintela,
  • Laura Madrid,
  • Antonio González-Pérez,
  • Laura Montrreal,
  • Emilio Alarcón-Martín,
  • Montserrat Alegret,
  • Olalla Maroñas,
  • Juan Antonio Pineda,
  • Juan Macías,
  • The GR@ACE study group,
  • DEGESCO consortium,
  • Marta Marquié,
  • Sergi Valero,
  • Alba Benaque,
  • Jordi Clarimón,
  • Maria Jesus Bullido,
  • Guillermo García-Ribas,
  • Pau Pástor,
  • Pascual Sánchez-Juan,
  • Victoria Álvarez,
  • Gerard Piñol-Ripoll,
  • Jose María García-Alberca,
  • José Luis Royo,
  • Emilio Franco-Macías,
  • Pablo Mir,
  • Miguel Calero,
  • Miguel Medina,
  • Alberto Rábano,
  • Jesús Ávila,
  • Carmen Antúnez,
  • Luis Miguel Real,
  • Adelina Orellana,
  • Ángel Carracedo,
  • María Eugenia Sáez,
  • Lluís Tárraga,
  • Mercè Boada,
  • Carlos Cruchaga,
  • Agustín Ruiz,
  • for the Alzheimer’s Disease Neuroimaging Initiative

DOI
https://doi.org/10.1038/s41398-020-01145-1
Journal volume & issue
Vol. 11, no. 1
pp. 1 – 12

Abstract

Read online

Abstract Long runs of homozygosity (ROH) are contiguous stretches of homozygous genotypes, which are a footprint of inbreeding and recessive inheritance. The presence of recessive loci is suggested for Alzheimer’s disease (AD); however, their search has been poorly assessed to date. To investigate homozygosity in AD, here we performed a fine-scale ROH analysis using 10 independent cohorts of European ancestry (11,919 AD cases and 9181 controls.) We detected an increase of homozygosity in AD cases compared to controls [β AVROH (CI 95%) = 0.070 (0.037–0.104); P = 3.91 × 10−5; β FROH (CI95%) = 0.043 (0.009–0.076); P = 0.013]. ROHs increasing the risk of AD (OR > 1) were significantly overrepresented compared to ROHs increasing protection (p < 2.20 × 10−16). A significant ROH association with AD risk was detected upstream the HS3ST1 locus (chr4:11,189,482‒11,305,456), (β (CI 95%) = 1.09 (0.48 ‒ 1.48), p value = 9.03 × 10−4), previously related to AD. Next, to search for recessive candidate variants in ROHs, we constructed a homozygosity map of inbred AD cases extracted from an outbred population and explored ROH regions in whole-exome sequencing data (N = 1449). We detected a candidate marker, rs117458494, mapped in the SPON1 locus, which has been previously associated with amyloid metabolism. Here, we provide a research framework to look for recessive variants in AD using outbred populations. Our results showed that AD cases have enriched homozygosity, suggesting that recessive effects may explain a proportion of AD heritability.